Maaike A. van der Aa

Radboud University Nijmegen

Papers

1

Total Citations

36

H-Index

1

About

Maaike A. van der Aa is a leading gynecologic oncologist whose research focuses on fertility-preserving treatments for cervical cancer, particularly in patients with larger tumors. Her major contribution is pioneering neoadjuvant chemotherapy followed by vaginal radical trachelectomy as an alternative to radical hysterectomy for FIGO 2018 stage 1B2 cervical cancer (tumors 2–4 cm). This work, published in 2020 and cited 36 times, demonstrates that fertility-sparing surgery can be safely extended to patients previously requiring hysterectomy, offering hope for preserving reproductive function without compromising oncological outcomes. Van der Aa’s research bridges the critical gap between aggressive cancer treatment and quality of life, showing that tumor size alone need not preclude fertility preservation. Her achievements include advancing surgical techniques that allow young women with cervical cancer to retain the possibility of childbearing, a paradigm shift in gynecologic oncology. By evaluating both oncological safety and fertility outcomes, she has established a new standard for patient-centered care in early-stage cervical cancer. Her work continues to influence clinical guidelines and inspire further research into neoadjuvant approaches for fertility preservation.

Research Focus

Key Achievements

1
H-Index
1
Papers
36
Total Citations
36
Avg Citations/Paper
🏆 Most Cited Paper
Neoadjuvant Chemotherapy Followed by Vaginal Radical Trachelectomy as Fertility-Preserving Treatment for Patients with FIGO 2018 Stage 1B2 Cervical Cancer
36 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Radboud University Nijmegen

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago